BRPI0922832A2 - nonapeptídeo com atividade antitumor - Google Patents

nonapeptídeo com atividade antitumor

Info

Publication number
BRPI0922832A2
BRPI0922832A2 BRPI0922832A BRPI0922832A BRPI0922832A2 BR PI0922832 A2 BRPI0922832 A2 BR PI0922832A2 BR PI0922832 A BRPI0922832 A BR PI0922832A BR PI0922832 A BRPI0922832 A BR PI0922832A BR PI0922832 A2 BRPI0922832 A2 BR PI0922832A2
Authority
BR
Brazil
Prior art keywords
nonapeptide
antitumor activity
antitumor
activity
Prior art date
Application number
BRPI0922832A
Other languages
English (en)
Inventor
Erik Haug Bengt
Sigurd Svendsen John
Amund Eriksen Jon
Rekdal Oystein
Original Assignee
Lytix Biopharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lytix Biopharma As filed Critical Lytix Biopharma As
Publication of BRPI0922832A2 publication Critical patent/BRPI0922832A2/pt
Publication of BRPI0922832B1 publication Critical patent/BRPI0922832B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922832-2A 2008-11-26 2009-09-11 Composto e composição com atividade antitumor e pacote farmacêutico BRPI0922832B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0821616.0 2008-11-26
GBGB0821616.0A GB0821616D0 (en) 2008-11-26 2008-11-26 Compounds
PCT/EP2009/006744 WO2010060497A1 (en) 2008-11-26 2009-09-11 A nonapeptide with anti-tumour activity

Publications (2)

Publication Number Publication Date
BRPI0922832A2 true BRPI0922832A2 (pt) 2018-11-06
BRPI0922832B1 BRPI0922832B1 (pt) 2021-08-24

Family

ID=40230868

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922832-2A BRPI0922832B1 (pt) 2008-11-26 2009-09-11 Composto e composição com atividade antitumor e pacote farmacêutico

Country Status (17)

Country Link
US (2) US9241968B2 (pt)
EP (2) EP2402364B1 (pt)
JP (2) JP5913982B2 (pt)
KR (2) KR20140084355A (pt)
CN (2) CN102232082B (pt)
AU (1) AU2009319454B2 (pt)
BR (1) BRPI0922832B1 (pt)
CA (1) CA2743986C (pt)
DK (1) DK2402364T3 (pt)
ES (1) ES2733129T3 (pt)
GB (1) GB0821616D0 (pt)
NZ (1) NZ593524A (pt)
PL (1) PL2402364T3 (pt)
RU (1) RU2503685C2 (pt)
SG (1) SG171823A1 (pt)
TR (1) TR201909522T4 (pt)
WO (1) WO2010060497A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
JP6813258B2 (ja) * 2014-12-11 2021-01-13 リティックス バイオファーマ エイエス 化学療法の組み合わせ
WO2016091490A1 (en) * 2014-12-11 2016-06-16 Lytix Biopharma As Chemotherapeutic combinations of cationic antimicrobial peptides and chemotherapeutics
JP6767096B2 (ja) * 2014-12-11 2020-10-14 リティックス バイオファーマ エイエス 免疫チェックポイント阻害剤の組み合わせ
GB201601868D0 (en) * 2016-02-02 2016-03-16 Lytix Biopharma As Methods
US20220213592A1 (en) 2019-04-04 2022-07-07 Adeka Corporation Raw material for forming thin film, method for producing thin film, and scandium compound
CN111150833B (zh) * 2020-03-16 2022-11-08 中国科学院微生物研究所 Ltx-315在制备抑制冠状病毒的产品中的应用
CN113549129B (zh) * 2021-06-10 2024-03-26 青岛大学 一种d-构型抗肿瘤肽及其制备方法和应用
CN119343360A (zh) * 2022-04-12 2025-01-21 北京锐瑟生物医药科技发展有限公司 溶瘤肽及其用途
KR20250122523A (ko) 2022-12-20 2025-08-13 리틱스 바이오파마 에이에스 종양 용해성 펩티드 및 키토산을 포함하는 조성물
CN120752049A (zh) 2022-12-20 2025-10-03 莱特克斯生物制药股份有限公司 包含肽的水性制剂的医用产品

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
DE69637731D1 (de) * 1995-08-23 2008-12-11 Univ British Columbia Antimikrobielle kationische peptide und methoden zu ihrer identifizierung
NO314086B1 (no) 1998-05-08 2003-01-27 Gemvax As Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
NO315238B1 (no) 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
US8283315B2 (en) * 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6303576B1 (en) 1999-04-21 2001-10-16 Adherex Technologies Inc. Compounds and methods for modulating β-catenin mediated gene expression
NO309798B1 (no) 1999-04-30 2001-04-02 Targovax As Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
RU2183643C1 (ru) * 2000-12-18 2002-06-20 Государственный научно-исследовательский институт особо чистых биопрепаратов Пептид, обладающий биоцидной активностью
GB0031430D0 (en) 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
GB0105238D0 (en) 2001-03-02 2001-04-18 Norsk Hydro As Vaccines
GB0112342D0 (en) 2001-05-21 2001-07-11 Norsk Hydro As Polypeptides
CN100427502C (zh) * 2005-06-09 2008-10-22 南京大学 抗肿瘤寡肽及其制备方法和应用
CN100486991C (zh) * 2005-09-27 2009-05-13 南开大学 与肿瘤转移细胞特异性结合的多肽及其应用
PL2061886T3 (pl) * 2006-08-21 2014-10-31 Univ British Columbia Małe kationowe peptydy immunomodulujące
CN101229362B (zh) * 2007-01-25 2010-08-18 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途
CN101284133B (zh) * 2007-04-10 2013-03-13 上海市肿瘤研究所 注射用整合素配体修饰的载药肿瘤靶向阳离子聚合物
CN101250219A (zh) * 2008-03-04 2008-08-27 福州大学 一种抑制白血病癌细胞生长的短肽系列及其应用
CN101302249B (zh) * 2008-06-24 2011-08-17 四川大学 一种自组装短肽及其在制备抗肿瘤药物中的应用
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds

Also Published As

Publication number Publication date
WO2010060497A1 (en) 2010-06-03
DK2402364T3 (da) 2019-07-01
JP5913982B2 (ja) 2016-05-11
SG171823A1 (en) 2011-07-28
CN102232082A (zh) 2011-11-02
ES2733129T3 (es) 2019-11-27
AU2009319454A1 (en) 2011-07-21
CA2743986C (en) 2016-10-11
US9241968B2 (en) 2016-01-26
AU2009319454B2 (en) 2013-01-17
TR201909522T4 (tr) 2019-07-22
JP2012509914A (ja) 2012-04-26
KR20110112303A (ko) 2011-10-12
EP2402364A2 (en) 2012-01-04
EP2402364A3 (en) 2012-07-11
KR20140084355A (ko) 2014-07-04
CN103304631A (zh) 2013-09-18
EP2361258A1 (en) 2011-08-31
PL2402364T3 (pl) 2019-10-31
EP2402364B1 (en) 2019-04-03
US20110318364A1 (en) 2011-12-29
RU2503685C2 (ru) 2014-01-10
JP2016138112A (ja) 2016-08-04
BRPI0922832B1 (pt) 2021-08-24
CA2743986A1 (en) 2010-06-03
GB0821616D0 (en) 2008-12-31
KR101445910B1 (ko) 2014-10-15
US20160176923A1 (en) 2016-06-23
NZ593524A (en) 2012-11-30
CN102232082B (zh) 2015-05-27

Similar Documents

Publication Publication Date Title
BRPI0922832A2 (pt) nonapeptídeo com atividade antitumor
BRPI0917980A2 (pt) subcanalização com aumento de potência
EP2288997A4 (en) DISTRIBUTED CACHE ARRANGEMENT
BRPI0914743A2 (pt) estrutura
BRPI0823070A2 (pt) Estrutura de tecido
BRPI0821498A2 (pt) Estrutura de queimador
EP2508411A4 (en) STRUCTURE
FI20085899A0 (fi) Puu-Metalli-komposiittirakenne
DK2490572T3 (da) Siddearrangement
BRPI0907670A2 (pt) conjunto de estrutura de aeronave
UA18855S (uk) Гіпертермотерапевтичне крісло
IT1390861B1 (it) Composti ad attività antimalarica
BRPI1013544A2 (pt) compostos com efeito fisiológico
FR2931492B1 (fr) Structure porteuse
UA19972S (uk) Сидіння
FR2954259B1 (fr) Piece de structure.
FR2956571B1 (fr) Structure de lit relevable
BRPI0924006A2 (pt) estrutura
UA18863S (uk) Підлокітник
FIU20080045U0 (fi) Sovitelma
TH100148B (th) ที่วางแขน
ITLE20080006A1 (it) Vanga con fulcro
PL2344512T3 (pl) Kompleks platyny o przeciwnowotworowej aktywności
TH99611B (th) เก้าอี้
TH104628B (th) เก้าอี้

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/09/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.